Vetter Pharma

🔍 Discover Vetter Development Services Austria! 🔍 At our facility in Rankweil, Vetter’s second clinical manufacturing site, we are focusing on delivering our customers high-quality services for Phase I and Phase II clinical batches. These include, for example, aseptic clinical filling, lyophilization as well as visual inspection and GMP-compliant storage of our customer’s products. Want to know more about Vetter Development Services Austria? Check out our video 🎥 and learn how we put our customer’s parenteral product on the path to clinical success. #earlystageclinicalmanufacturing

🌱 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 – 𝐆𝐨𝐚𝐥𝐬 𝐚𝐧𝐝 𝐁𝐞𝐬𝐭 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 | 𝐕𝐞𝐭𝐭𝐞𝐫  Climate change and limited natural resources are among the greatest challenges of our time. The gradual transition to a more sustainable, climate-friendly and resource-friendly society is both difficult and inevitable. 🌍   Over the next few weeks, we would like to highlight the areas in which the BioPharma Cluster South Germany members are driving this sustainable transformation forward. Today, with Henryk Badack, Senior Vice President Technical Service and Internal Project Management, who is responsible for the global sustainability initiatives at Vetter Pharma.   “Sustainability is anchored in Vetter’s DNA and corporate philosophy. A strong sustainability strategy is not just good business but reflects our role in the value chain. We embody this strategy through a three-pillar approach encompassing social, economic and ecological sustainability.   We published our first sustainability report in 2022. Here we addressed outcomes related to our adherence to the German Sustainability Code (DNK) and the Sustainability Report Standards (SRS) of the Global Reporting Initiative (GRI).   In 2023 our EcoVadis ranking rose to platinum status, placing us in the top one percent of companies assessed globally, and we joined the Science Based Targets initiative (SBTi) to demonstrate our engagement in initiatives to counter climate change. Internally, we established a sustainability management system that monitors and tracks all relevant activities and identifies areas for action. The attitudes and commitment of Vetter’s owner families and management are particularly important, as their support makes these initiatives a priority companywide.   We address sustainability holistically. This includes offerings for our employees and their families such as free access to supplemental health insurance and counseling or mobility options such as bike leasing and free transit tickets for public transportation. Simultaneously, we’ve completed more than 125 efficiency projects in the last decade, saving the energy consumption equivalent of 60,000 family homes. Despite a fourfold increase in our workforce, this demonstrates our commitment to reduce environmental impact and drive sustainable growth.   As a pharmaceutical service provider, we need to adhere to special requirements, resulting in resource-intensive production processes. This means we strive to improve the efficiency of our infrastructure and drive forward technological transformations. For us, sustainability is not a label, it’s an attitude.”   ---   The BioPharma Cluster South Germany creates an attractive, cross-functional and innovation-driven environment for the research, development and production of biopharmaceuticals and therapies. By focusing on technology, talent and society, we strengthen healthcare as a whole for the benefit of patients worldwide.   #BioPharma #Biotech #Sustainability #BioPharmaSustain

🔍 Discover our Development Service Site in the US! 🔍 Located in the Illinois Science and Technology Park in Skokie, just outside Chicago, we specialize in early-stage clinical manufacturing. Our mission? To build flexible, scalable, and highly effective processes for our customers. Our facility features two state-of-the-art clean rooms: • One dedicated to filling pre-sterilized syringes • Another for both liquid and lyophilized vials Our passionate team of over 100 experts is here to support our customers at every step—besides aseptic filling, for example, in navigating regulatory questions and developing testing methods to bring their parenteral product on the path to clinical success. #EarlyStageClinicalManufacturing #HighQualityProducts #ManufacturingExcellence

Ciao da Milano! CPHI Milan 2024 is in full swing, and we're thrilled to be part of the excitement once again! Our colleagues on site are having a fantastic time connecting with industry partners and sharing our passion for aseptic fill & finish. If you're attending as well, stop by booth #7A66 to meet with them—they’d love to discuss your projects and how we can help you advance your parenteral product! 🤝💡💉 #CPhI #CDMO #Innovation #PharmaEvent


Early stage clinical manufacturing is a critical step in bringing new therapies to market. At Vetter, we believe that the foundation of successful injectable drug product development lies in thoughtful processes, meticulous methods, and strategic component selections. That’s why we work closely with our customers on these key development activities, supporting them with our deep expertise in the complexities of aseptic processes. Our goal? To bring our customer’s valuable injectable product on the path of clinical success. Click here to learn more: https://lnkd.in/ech9SCtQ #AsepticProcesses

Are you in the early stages of product development for an injectable drug? Then you won't want to miss our latest video featuring Jörg Zimmermann, Pharmacist and Vice President External Affairs at Vetter. 
 In this informative video, Jörg shares his top 5 tips on how to select the right primary container for your injectable drug product. He discusses the various factors that need to be considered when exploring container options beyond vials, including patients' evolving needs, the optimal container, injection device plans, import-export regulations, and deviation from standard components. Don't miss out on this valuable information that could make all the difference in the success of your product development. Check out our video now! #pharmaceuticals #productdevelopment #injectabledrugs #containers #expertadvice

My fellow managing director, Thomas Otto, and I are excited to share some fantastic news: Vetter Pharma has been honored with several prestigious HR awards!  First, it's a double honor to be recognized by the Frankfurter Allgemeine Zeitung – one of the leading journalist voices in Germany – as both one of "Germany's most desired employers" and "Germany's apprenticeship champion" in the #pharma sector. We’ve also earned the "Top Apprenticeship Award" from the LEADING EMPLOYERS institute – a first for Vetter and a clear reflection of our commitment to nurturing the next generation of talent through robust apprenticeship programs. These accolades reflect the dedication of our whole team and underscore their unwavering commitment to our employees, starting with our youngest colleagues. As we continue to grow and advance our business to serve patients in need worldwide, our people remain the cornerstone of our success. We will not just keep, but rather further increase, our apprenticeship figures and initiatives.  Why? Because we know that modern, high-quality apprenticeships like ours are a huge opportunity to pass on an enterprise’s unique DNA and core values over decades. I'd like to take this opportunity to express our gratitude to all our Vetter employees – including Claudia Roth and her team – for their tireless work in cultivating a culture of continuous education. The passion for enhancing the skills and knowledge of our 6,600+ employees, including our bright young apprentices, is truly inspiring. Finally, a heartfelt thank you to Leading Employers and the Frankfurter Allgemeine Zeitung for these strong recognitions. They serve as a powerful reminder of our ongoing responsibility to maintain a workplace that not only attracts top talent, but also fosters their growth and inspires them to stay with us long-term. #CDMO #EmployerOfChoice #FutureOfWork #TalentDevelopment 

If you're looking for a reliable and experienced partner to help you get your parenteral product on the path to clinical success, Vetter Development Service may be the one for you. For example, did you know that our #ClinicalManufacturing facilities in Skokie, Illinois and Rankweil, Austria have a proven track record of successfully onboarding over 40 new projects annually, with 80% of them involving complex biologics? Our expert teams understand the unique challenges that come with developing parenteral products and have the expertise to guide you through the process. Let us know how we can support you. For more infos, click here: https://lnkd.in/em_XHmY4

Buongiorno, #pharma community! As always, we're thrilled to be exhibiting at CPHI in stunning Milan 🤝 This is a fantastic opportunity to engage with industry leaders and explore the latest advancements in pharmaceutical development and manufacturing. We can't wait to share our insights and expertise with you! If you're interested in partnering or want to learn more about Vetter's aseptic fill & finish capabilities, reach out to Sebastian Müller, Stefan Conrad, and Tobias Schlögl! They would love to meet with you! See you there! #CPhI #IndustryEvent #Innovation

If you missed our webcast on #clinicalmanufacturing, don't worry: you still have the opportunity to learn the insights of our experts! This special presentation was delivered by two subject matter experts in early-stage #asepticmanufacturing, Garath Duffy and Dr. Oliver Okle. Together they offered some very valuable guidance for up-and-coming drug developers and their first critical batch of clinical trial material. If you’re preparing for clinical trials of a #sterileinjectable, we highly recommend making time for this on-demand webcast. Find a link to the full presentation in the comments. https://lnkd.in/eTrG4FmP